Qingdao Vland Biotech Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Qingdao Vland Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Qingdao Vland Biotech Co Ltd (603739) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.29 Million ≈ $3.55 Million USD) by net assets (CN¥1.90 Billion ≈ $278.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Qingdao Vland Biotech Co Ltd (2014–2024)

Cash flow conversion efficiency of Qingdao Vland Biotech Co Ltd from 2014 to 2024. This chart illustrates how Qingdao Vland Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 603739 live share price for real-time trading data and today's change.

Qingdao Vland Biotech Co Ltd Cash Flow Conversion Ratio Explained

Qingdao Vland Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Qingdao Vland Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qingdao Vland Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Qingdao Vland Biotech Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
HaiXin Foods Co Ltd SHE:002702	0.122x
Lafang China SHG:603630	0.030x
Ovzon AB ST:OVZON	0.051x
Magnera Corp placeholder NYSE:MAGN	-0.013x
Kolte - Patil Developers Limited NSE:KOLTEPATIL	0.136x
Shanghai HIUV New Materials Co Ltd SHG:688680	0.069x
CW Enerji SA IS:CWENE	0.013x
Shyft Group Inc NASDAQ:SHYF	-0.018x

Annual Cash Flow Conversion Efficiency for Qingdao Vland Biotech Co Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Qingdao Vland Biotech Co Ltd from 2014 to 2024. Review Qingdao Vland Biotech Co Ltd (603739) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.87 Billion ≈ $273.64 Million	CN¥195.41 Million ≈ $28.59 Million	0.104x	+24.19%
2023-12-31	CN¥1.83 Billion ≈ $267.11 Million	CN¥153.59 Million ≈ $22.48 Million	0.084x	+53.08%
2022-12-31	CN¥1.73 Billion ≈ $253.73 Million	CN¥95.31 Million ≈ $13.95 Million	0.055x	+3.50%
2021-12-31	CN¥1.69 Billion ≈ $246.65 Million	CN¥89.51 Million ≈ $13.10 Million	0.053x	-65.76%
2020-12-31	CN¥1.12 Billion ≈ $163.20 Million	CN¥173.00 Million ≈ $25.31 Million	0.155x	+145.11%
2019-12-31	CN¥1.03 Billion ≈ $151.05 Million	CN¥65.33 Million ≈ $9.56 Million	0.063x	-53.40%
2018-12-31	CN¥631.38 Million ≈ $92.39 Million	CN¥85.75 Million ≈ $12.55 Million	0.136x	-33.98%
2017-12-31	CN¥592.53 Million ≈ $86.71 Million	CN¥121.90 Million ≈ $17.84 Million	0.206x	-25.70%
2016-12-31	CN¥557.97 Million ≈ $81.65 Million	CN¥154.49 Million ≈ $22.61 Million	0.277x	+93.62%
2015-12-31	CN¥519.36 Million ≈ $76.00 Million	CN¥74.27 Million ≈ $10.87 Million	0.143x	+13.88%
2014-12-31	CN¥466.26 Million ≈ $68.23 Million	CN¥58.55 Million ≈ $8.57 Million	0.126x	--

About Qingdao Vland Biotech Co Ltd

SHG:603739 China Biotechnology

Market Cap

$439.13 Million

CN¥3.00 Billion CNY

Market Cap Rank

#12561 Global

#3667 in China

Share Price

CN¥11.86

Change (1 day)

-3.10%

52-Week Range

CN¥10.81 - CN¥16.74

All Time High

CN¥58.91